IL-12B

IL-12B

IL-12B 분자 정보

Molecule Name
Interleukin-12 subunit beta
분자 별명
IL12B,CLMF,CLMF2,NKSF,NKSF2,p40
Drug Development Progress
임상 약물 수2
시판 약물 수8
최고 연구 개발 단계Approved
표적 별명
IL-12B,NK cell stimulatory factor chain 2,IL12B,Interleukin 12B,Interleukin 12B (Natural Killer Cell Stimulatory Factor 2, Cytotoxic Lymphocyte Maturation Factor 2, P40),Cytotoxic Lymphocyte Maturation Factor 40 KDa Subunit,Interleukin-12 Beta Chain,Interleukin 12, P40,IL12, Subunit P40,CLMF P40,NKSF2,Cytotoxic Lymphocyte Maturation Factor 2, P40,Interleukin-12 Subunit Beta,CLMF2,IMD28,IMD29,CLMF,NKSF,Interleukin-12 Subunit p40,Natural Killer Cell Stimulatory Factor, 40 KD Subunit,IL-12 Subunit P40,Natural Killer Cell Stimulatory Factor-2
분자 배경
Interleukin-12 (IL12) is also known as natural killer cell stimulatory factor (NKSF), cytotoxic lymphocyte maturation factor (CLMF) , is a heterodimeric cytokine encoded by two separate genes, IL-12A (p35) and IL-12B (p40). IL12 is naturally produced by dendritic cells, macrophages and human B-lymphoblastoid cells (NC-37) in response to antigenic stimulation. IL-12 is involved in the differentiation of naive T cells into Th0 cells and plays an important role in the activities of natural killer cells and T lymphocytes.IL-12 also has anti-angiogenic activity, which means it can block the formation of new blood vessels. Interleukin-12 subunit beta (IL12B) also known as NKSF2, CLMF2 and P40. Interleukin-12 subunit beta has been shown to interact with IL23. A large excess of monomeric IL12B is also secreted by the cells producing IL12, and exhibits no demonstrable biological activity. Overexpression of IL12B gene has been shown to be associated with the pathogenesis of multiple sclerosis. In addition, studies have revealed that the promoter polymorphism of this gene is implicated in the severity of atopic and non-atopic asthma in children.

IL-12B 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
RO-7837195RO-7837195; RO7837195Phase 2 ClinicalGenentech Inc
Colitis, Ulcerative
상세
PF-07261271RG-6730; PF-07261271Phase 2 ClinicalPfizer Inc
Inflammatory Bowel Diseases
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Ustekinumab biosimilar (Bio-Thera)BAT-2206ApprovedBio-Thera Solutions LtdSTARJEMZA, UsymroUnited StatesPlaque psoriasis; Crohn Disease; Colitis, Ulcerative; Arthritis, PsoriaticBio-Thera Solutions Ltd2025-05-22
Arthritis, Psoriatic; Autoimmune Diseases; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis; Psoriasis
상세
UstekinumabC-340; CNTO-1275ApprovedJohnson & Johnson Innovative MedicineStelara, 喜达诺United StatesPlaque psoriasisJanssen Biotech Inc2009-09-25
Arthritis, Juvenile; Arthritis, Psoriatic; Colitis, Ulcerative; Common Variable Immunodeficiency; Crohn Disease; Dermatitis, Atopic; Dermatomyositis; Diabetes Mellitus, Type 1; Hidradenitis Suppurativa; Ichthyosis; Inflammatory Bowel Diseases; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Multiple Sclerosis; Palmoplantar pustulosis; Pediatric Crohn's disease; Plaque psoriasis; Polymyositis; Pouchitis; Psoriasis; Sjogren's Syndrome; Spondylitis, Ankylosing; Takayasu Arteritis; Type I Leukocyte Adhesion Defect; Uveitis
상세
EbdarokimabAK-101; AK101Approved爱达罗Mainland ChinaPlaque psoriasisZhongshan Akeso Biopharma Co Ltd2025-04-15
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis; Psoriasis
상세
Ustekinumab Biosimilar(Celltrion)CT-P43ApprovedCelltrion IncSteqeyma, Steqeyma IV, QoyvolmaCanadaArthritis, Psoriatic; Crohn Disease; Plaque psoriasisCelltrion Inc2024-08-01
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis; Psoriasis
상세
Ustekinumab biosimilar (Biocon)Bmab 1200ApprovedBiocon Biologics LtdYesintekUnited StatesColitis, Ulcerative; Crohn Disease; Arthritis, PsoriaticBiocon Biologics Inc2024-11-29
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis; Psoriasis
상세
Ustekinumab biosimilar (Alvotech)AVT04; AVT-04ApprovedAlvotech hfJamteki, Uzpruvo, SELARSDI™, JamtekiTM, Ustekinumab BS (F)JapanArthritis, Psoriatic; PsoriasisFuji Pharma Co Ltd2023-09-25
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis; Psoriasis
상세
Ustekinumab biosimilar (Samsung Bioepis)SB-17; SB17ApprovedSamsung Bioepis Co LtdPyzchiva, EksunbiEUCrohn Disease; Colitis, UlcerativeSamsung Bioepis Nl Bv2024-04-19
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Diseases; Inflammation; Plaque psoriasis; Psoriasis; Rheumatic Diseases; Skin Diseases
상세
Ustekinumab biosimilar (Amgen)ABP-654; AMG-654ApprovedAmgen IncWezlana, WEZLANA, wezenla, WEZENLAUnited StatesCrohn Disease; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasisAmgen Inc2023-10-31
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis; Psoriasis
상세